A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG09.02 (CHISEL)

被引：28

作者：

Ball, D. ^{[1
]}

Mai, T. ^{[2
]}

Vinod, S. ^{[3
]}

Babington, S. ^{[4
]}

Ruben, J. ^{[5
,6
]}

Kron, T. ^{[1
]}

Chesson, B. ^{[1
]}

Herschtal, A. ^{[1
]}

Rezo, A. ^{[7
]}

Elder, C. ^{[8
]}

Skala, M. ^{[9
]}

Wirth, A. ^{[1
]}

Wheeler, G. ^{[1
]}

Lim, A. ^{[10
]}

Vanevski, M. ^{[1
]}

Shaw, M. ^{[1
]}

机构：

[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Princess Alexandra Hosp, Brisbane, Qld, Australia

[3] Liverpool Hosp, Canc Therapy Ctr, Liverpool, NSW, Australia

[4] Christchurch Hosp, Christchurch, New Zealand

[5] William Buckland Radiotherapy Ctr, Radiat Oncol, Melbourne, Vic, Australia

[6] Monash Univ, Melbourne, Vic, Australia

[7] Canberra Hosp, Canberra, ACT, Australia

[8] Auckland Hosp, Auckland, New Zealand

[9] Royal Hobart Hosp, Hobart, Tas, Australia

[10] Austin Hosp, Melbourne, Vic, Australia

来源：

关键词：

phase III randomized trial; Stereotactic ablative body radiotherapy; stage I non-small cell lung cancer;

D O I：

10.1016/j.jtho.2017.09.565

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

MA 13.07

引用

页码：S1853 / S1853

页数：1